May 16, 2017 7:40am

 

…  Still get no respect

Quarterly results are important, but cell therapy stocks in particular have more than a lot to prove each three-month period.

 

… Let’s play sell once more so we can buy again

 

Mixed open expected

Companies in my headlights: eight (8), 2 BUY and 6 SELLs

 

Critical information ahead of “our” universe’s open! I provide intelligence and analysis for short and near-term investment.

 


Members only. Please login.